|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 59.57M 4.55M 4.19M 3.87M 7.35M 496M 7.47M 50.09M 19.67M 244M 19.51M 19.09M 839M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 120M 9.14M 8.43M 7.78M 14.77M 996M 15.02M 101M 39.54M 491M 39.22M 38.37M 1.69B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| Average | -1.18% | -3.25% | +26.72% | +56.70% | 357.39B | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.91% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 102M 7.78M 7.17M 6.63M 12.57M 848M 12.79M 85.72M 33.66M 418M 33.39M 32.66M 1.44B | 9.91M 114M 8.67M 8M 7.38M 14.01M 945M 14.25M 95.53M 37.51M 466M 37.21M 36.4M 1.6B |
| Net income | 665K 7.62M 582K 537K 496K 940K 63.43M 956K 6.41M 2.52M 31.25M 2.5M 2.44M 107M | 762K 8.73M 666K 614K 567K 1.08M 72.63M 1.09M 7.34M 2.88M 35.78M 2.86M 2.8M 123M |
| Net Debt | 4.15M 47.54M 3.63M 3.35M 3.09M 5.86M 396M 5.96M 39.98M 15.7M 195M 15.57M 15.23M 670M | 5.25M 60.18M 4.59M 4.24M 3.91M 7.42M 501M 7.55M 50.61M 19.87M 247M 19.71M 19.28M 848M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
